Portal Instruments

10 articles about Portal Instruments

• LEO Pharma and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery Device

  12/4/2019

  LEO Pharma A/S and Portal Instruments announced a global collaboration and license agreement to develop Portal’s innovative needle-free drug delivery system for use in combination with LEO Pharma’s portfolio of investigational and approved medicines.

• Patrick Anquetil, Chief Executive Officer of Portal Instruments, to Speak at 2018 BIO International Convention in Boston

  6/1/2018

  Anquetil will discuss how Portal Instruments’ connected drug-delivery system differentiates pharmaceutical company brands and creates a better healthcare experience.

• 

  Takeda, Portal Instruments Ink $100M Deal to Develop Needle-Free Drug Delivery Device

  11/7/2017

  Takeda inked a collaboration deal to develop and commercialize Portal's needle-free drug delivery device for use with some of Takeda's biologic medicines.

• Portal Instruments Appoints Wendy Dwyer As Chief Business Officer

  7/11/2017

• Needle-Free Viscous Drug Injections: Interview With CEO Of Portal Instruments

  7/5/2017

• Portal Instruments Marks Milestone, Publishing Results Of Study In Peer-Reviewed Article In American Association of Pharmaceutical Scientists Pharmscitech

  5/17/2017

• Portal Instruments Receives ISO 13485:2012 Certification From NSAI

  4/24/2017

• Portal Instruments Adds Two Esteemed Biotechnology Leaders To Its Scientific Advisory Board

  9/1/2016

• Portal Instruments Receives the Company On the Rise Award at the Drug Delivery Partnerships Annual Meeting

  1/28/2016

• Portal Instruments Closes A $25 Million Series B Financing To Commercialize Its Transformative Needle-Free Drug Delivery System

  10/20/2015